We are live on ! Find out more
LIM

Lagoda Investment Management Portfolio holdings

AUM $162M
1-Year Est. Return 49.7%
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$375M
AUM Growth
Cap. Flow
+$370M
Cap. Flow %
98.82%
Top 10 Hldgs %
68.18%
Holding
47
New
47
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 46.56%
2 Financials 21.42%
3 Communication Services 6.63%
4 Materials 5.99%
5 Technology 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$78.5B
$37.9M 10.1%
+92,271
New +$36.3M
ALXN
2
DELISTED
Alexion Pharmaceuticals
ALXN
$37.1M 9.9%
+200,465
New +$37.1M
BRK.A icon
3
Berkshire Hathaway Class A
BRK.A
$1.1T
$26M 6.94%
+115
New +$24.9M
NVO
4
Novo Nordisk
NVO
$208B
$25.3M 6.74%
+1,193,618
New +$26.7M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.36T
$24.8M 6.63%
+942,460
New +$25.3M
MON
6
DELISTED
Monsanto Co
MON
$22.3M 5.94%
+186,324
New +$21.6M
GLW icon
7
Corning
GLW
$119B
$21.5M 5.74%
+938,204
New +$19.1M
RNR icon
8
RenaissanceRe
RNR
$13.3B
$21.1M 5.64%
+217,325
New +$21.6M
BN icon
9
Brookfield
BN
$104B
$20M 5.35%
+1,706,696
New +$19.2M
SNMX
10
DELISTED
Senomyx, Inc.
SNMX
$19.5M 5.21%
+3,245,472
New +$20.8M
ALSN icon
11
Allison Transmission
ALSN
$9.5B
$18.5M 4.94%
+546,223
New +$17.4M
MACK
12
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$17.6M 4.71%
+198,343
New +$14.4M
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
$17.5M 4.68%
+545,426
New +$19M
JNJ icon
14
Johnson & Johnson
JNJ
$618B
$14.8M 3.95%
+141,624
New +$14.9M
HP icon
15
Helmerich & Payne
HP
$3.45B
$13.8M 3.67%
+203,975
New +$15.9M
GOLD
16
DELISTED
Randgold Resources Ltd
GOLD
$13.5M 3.59%
+202,684
New +$13.2M
BRK.B icon
17
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.56M 1.48%
+37,038
New +$5.35M
ESGR
18
DELISTED
Enstar Group
ESGR
$4.17M 1.11%
+27,280
New +$3.96M
BHC icon
19
Bausch Health
BHC
$2.58B
$3.71M 0.99%
+25,934
New +$3.49M
MA icon
20
Mastercard
MA
$502B
$2.9M 0.77%
+33,697
New +$2.75M
ROK icon
21
Rockwell Automation
ROK
$53.4B
$2.04M 0.54%
+18,306
New +$2.01M
NJ
22
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$1.3M 0.35%
+80,140
New +$1.3M
ISRG icon
23
Intuitive Surgical
ISRG
$127B
$916K 0.24%
+15,588
New +$868K
XOM icon
24
ExxonMobil
XOM
$644B
$585K 0.16%
+6,333
New +$591K
Y
25
DELISTED
Alleghany Corp
Y
$368K 0.1%
+795
New +$354K

Similar funds

Lagoda Investment Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Lagoda Investment Management, which disclosed 47 positions worth $375M. Its ten largest holdings account for 68% of the portfolio.

Its largest position is Alexion Pharmaceuticals: 200,465 shares worth $37.1M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, followed by Financials and Communication Services.

  • Lagoda Investment Management's largest Q4 2014 buy was Alexion Pharmaceuticals: 200,465 shares worth $37.1M.
  • Lagoda Investment Management's ten largest holdings make up 68% of its $375M portfolio in Q4 2014.
  • Lagoda Investment Management disclosed 47 positions in Q4 2014, its first 13F filing on record.

Based on Lagoda Investment Management's 13F filing for Q4 2014, filed 17 Feb 2015.